Supernus Pharmaceuticals | SUPN - PE价格收益

金融业

USD

USD 1.45B

现金及等价物

USD 151.37M

USD 47.53M

USD 644.18M

USD 338.17M

USD 42.21M

USD 13.82M

USD 48.5M

674

EPS每股收益

USD -0.07

股本和储备

USD 1.06B

USD 164.04M

债务利息支出

USD 910K

USD 2.28M

USD 400.38M

USD 2.78B

USD -45.12M

USD 197.75M

USD 13.82M

普通股股本

USD 57.12M

110.38

USD -1.91M

USD 211.6M

销售和管理费用

USD 122.39M

USD 107.1M

贸易债权人

USD 107.8M

应收帐款人

USD 187.8M

	Pe	更改		日
Abbott	30.71		14.41	2025-12
ANI Pharmaceuticals	37.99		60.68	2025-12
Aurora Cannabis	23.27		0	2025-09
Bristol-Myers Squibb	9.28		1.04	2025-12
Cara Therapeutics	27.77		117.09	2021-09
Corcept Therapeutics	41.9		52.28	2025-12
Eisai	26.63		0.46	2025-12
Eli Lilly	40.21		9.66	2025-12
Novo Nordisk	12.78		0.01	2025-12
Pacira	52.68		23.44	2025-12
Perrigo	58.96		24.65	2025-12
Pfizer	14.48		5.18	2025-12
Supernus Pharmaceuticals	110.38		71.27	2025-12
United Therapeutics	17.32		1.62	2025-12